2 months ago
15 ARTICLE AD
A wildly popular diabetes and weight-loss drug may also protect people from overdosing on opioids.
That’s the implication of a new study that examined health records of people with type 2 diabetes and opioid use disorder. People prescribed semaglutide, which is sold under the brand names Ozempic and Wegovy, were roughly one-third to one-half as likely to overdose on opioids during a one-year follow-up as people prescribed a different diabetes drug.
“It’s a big decrease,” says Rong Xu, an AI and biomedical researcher at Case Western Reserve University in Cleveland whose team reports the findings September 25 in JAMA Network Open.
